share_log

Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate

Olema Pharmaceuticals Q4 EPS $(0.49) Misses $(0.48) Estimate

Olema Pharmaceuticals第四季度每股收益美元(0.49美元)未達到預期(0.48美元)
Moomoo 24/7 ·  03/11 16:04

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 24.62 percent increase over losses of $(0.65) per share from the same period last year.

奧萊瑪製藥(納斯達克股票代碼:OLMA)公佈的季度虧損爲每股0.49美元,比分析師普遍預期的0.48美元(0.48美元)低2.08%。這比去年同期每股虧損0.65美元(0.65)增長了24.62%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論